1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 18 JANUARY 2016

CNS Drug News 18 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Takeda's Recovery Will Be Rooted In Development Partnerships
Industry Brief - Zambon Launches Xadago For PD In Switzerland
Industry Trend Analysis - Biotie Acquisition Underscores Acorda's Focus On Parkinson's Need
Industry Brief - Neurotrope Initiates Phase IIb Study Of Bryostatin For Alzheimer's Disease
Industry Brief - Probiodrug's pGlu-Abeta For AD Granted Japanese/US Patents
Industry Brief - Alector Closes USD29.5mn Series D Financing
Industry Brief - EMD Serono Takes Exclusive Promotion Of Rebif In US
Industry Trend Analysis - Focus On Partnership Securing Results For Ionis
Industry Trend Analysis - BrainStorm Building On Strong Results In ALS
Industry Trend Analysis - Risperdal Controversy Costs Continue To Rise
Industry Brief - Tribute Granted Canadian Patent Allowance Expanding Cambia Use
Industry Brief - Ipsen/Galderma Expand Dysport Distribution Deal
Industry Brief - BioQ And Cipla Enter Ropivacaine Agreement
Industry Brief - AcelRx Plans Additional Zalviso Phase III Trial
Industry Trend Analysis - Positive PDAC Opinion Puts Probuphine On Track For FDA Approval
Industry Trend Analysis - Positive Results Raise Acacia IPO Potential
Industry Trend Analysis - Serious Side-Effects In Bial Trial Will Raise Development Scrutiny
Industry Trend Analysis - Lilly Stabilising After Patent Slump
Industry Brief - Shire To Combine With Baxalta
Industry Trend Analysis - Collaboration Key To Arena And BI's Neuroscience Research
Industry Trend Analysis - Precision Medicine Focus To Increase CNS Pipeline Success
Industry Brief - CNS Conferences - April 2016

Table Of Contents

CNS Drug News 18 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.